Inhibition of tumor progression using antisense oligonucleotide targeting Gli2 in androgen independent prostate cancer

被引：0
|
作者：
Narita, Shintaro
So, Alan I.
Sinnemann, Shannon
Fazli, Ladan
Marcusson, Eric G.
Gleave, Martin E.
机构：
来源：
JOURNAL OF UROLOGY | 2007年 / 177卷 / 04期
关键词：
D O I：
10.1016/S0022-5347(18)30415-4
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：51 / 51
页数：1
相关论文
共 50 条
  • [31] Creation of androgen independent prostate cancer cell lines using targeting nucleases.
    Nyquist, Michael D.
    Li, Yingming
    Dehm, Scott M.
    CANCER RESEARCH, 2013, 73 (08)
  • [32] HOTAIR and androgen receptor synergistically increase GLI2 transcription to promote tumor angiogenesis and cancer stemness in renal cell carcinoma
    Bai, Ji-Yu
    Jin, Ben
    Ma, Jian-Bin
    Liu, Tian-Jie
    Yang, Chao
    Chong, Yue
    Wang, Xinyang
    He, Dalin
    Guo, Peng
    CANCER LETTERS, 2021, 498 : 70 - 79
  • [33] IDENTIFICATION OF THE BINDING DOMAINS THAT ENABLE THE LIGAND-INDEPENDENT CO-ACTIVATION OF ANDROGEN RECEPTOR BY GLI2
    Li, Na
    Chen, Mengqian
    Buttyan, Ralph
    JOURNAL OF UROLOGY, 2013, 189 (04): : E206 - E206
  • [34] Gli2 induces melanoma tumor growth and progression: A critical role of c-Myc
    Fofaria, Neel Manoj
    Srivastava, Sanjay K.
    CANCER RESEARCH, 2015, 75
  • [35] Prostate cancer: Loss of PTEN promotes progression of prostate cancer in an androgen-independent manner
    Warde N.
    Nature Reviews Urology, 2011, 8 (8) : 412 - 412
  • [36] Inhibition of LNCaP prostate cancer cells by means of androgen receptor antisense oligonucleotides
    Iris E Eder
    Zoran Culig
    Reinhold Ramoner
    Martin Thurnher
    Thomas Putz
    Claudia Nessler-Menardi
    Martin Tiefenthaler
    Georg Bartsch
    Helmut Klocker
    Cancer Gene Therapy, 2000, 7 : 997 - 1007
  • [37] Inhibition of LNCaP prostate tumor growth in vivo by an antisense oligonucleotide directed against the human androgen receptor (vol 9, pg 117, 2002)
    Eder, I. E.
    Hoffmann, J.
    Rogatsch, H.
    Schaefer, G.
    Zopf, D.
    Bartsch, G.
    Klocker, H.
    CANCER GENE THERAPY, 2007, 14 (11) : 934 - 934
  • [38] Inhibition of LNCaP prostate cancer cells by means of androgen receptor antisense oligonucleotides
    Eder, IE
    Culig, Z
    Ramoner, R
    Thurnher, M
    Putz, T
    Nessler-Menardi, C
    Tiefenthaler, M
    Bartsch, G
    Klocker, H
    CANCER GENE THERAPY, 2000, 7 (07) : 997 - 1007
  • [39] Potential increase in androgen sensitivity following antisense oligonucleotide suppression of Bcl-2 in a prostate cancer model.
    Guinan, Patrick
    Rubenstein, Marvin
    Hollowell, Courtney M. P.
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [40] Targeting androgen receptor and JunD interaction for prevention of prostate cancer progression
    Mehraein-Ghomi, Farideh
    Kegel, Stacy J.
    Church, Dawn R.
    Schmidt, Joseph S.
    Reuter, Quentin R.
    Saphner, Elizabeth L.
    Basu, Hirak S.
    Wilding, George
    PROSTATE, 2014, 74 (07): : 792 - 803
12345